Epidemiology of Sjögren syndrome

被引:37
|
作者
Beydon, Maxime [1 ]
McCoy, Sara [2 ]
Nguyen, Yann [1 ,3 ]
Sumida, Takayuki [4 ]
Mariette, Xavier [1 ,3 ]
Seror, Raphaele [1 ,3 ]
机构
[1] Univ Paris Saclay, Bicetre AP HP Hop, Dept Rheumatol, Paris, France
[2] Univ Wisconsin Madison, Dept Med, Madison, WI USA
[3] Univ Paris Saclay, Ctr Immunol Viral Infect & Autoimmune Dis, INSERM U1184, Le Kremlin Bicetre, France
[4] Univ Tsukuba, Dept Internal Med, Tsukuba, Japan
关键词
PRIMARY SJOGRENS-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NON-HODGKIN-LYMPHOMA; QUALITY-OF-LIFE; AUTOIMMUNE RHEUMATIC-DISEASES; CLASSIFICATION CRITERIA; SICCA SYMPTOMS; CLINICAL CHARACTERISTICS; FOLLOW-UP; INTERNATIONAL-CLASSIFICATION;
D O I
10.1038/s41584-023-01057-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sjogren syndrome is a phenotypically varied autoimmune disorder that can occur alone in primary Sjogren syndrome or in association with other connective tissue diseases (CTDs), including rheumatoid arthritis, systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). The estimation of the prevalence and incidence of Sjogren syndrome varies depending on diagnostic criteria and study design, making it difficult to estimate geographical and temporal trends. Nonetheless, disease phenotype is influenced by geographical origin, which is a risk factor for systemic activity. Whether mortality in primary Sjogren syndrome is increased compared with that of the general population is not yet known, but extra-glandular manifestations, in particular lymphomas, are clear risk factors for mortality. In CTDs associated with Sjogren syndrome, lymphoma risk seems higher than that of patients with CTD alone, and there is potentially lower disease activity in SLE with Sjogren syndrome and in SSc with Sjogren syndrome than in SLE or SSc alone. In this epidemiological Review, the authors summarize the available evidence relating to the prevalence, incidence, risk factors and mortality associated with the autoimmune disorder Sjogren syndrome, with or without the co-occurrence of other connective tissue diseases. Primary Sjogren syndrome (pSS) affects mostly women, with age at disease onset as well as systemic activity varying according to geographical origin.Assessment of the prevalence of pSS varies according to study methodology, but can be estimated at between 0.01% and 0.05%, although some countries might be under-represented in this estimation.Mortality in pSS seems to be elevated predominantly in patients with extra-glandular manifestations, pulmonary involvement and non-Hodgkin lymphoma.pSS is the autoimmune disease with the most important increased risk of non-Hodgkin lymphoma, especially among patients with extra-glandular manifestations or systemic activity, low complement levels, cryoglobulinaemic vasculitis or rheumatoid factor positivity.Sjogren syndrome can be associated with other connective tissue diseases, mainly rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
引用
收藏
页码:158 / 169
页数:12
相关论文
共 50 条
  • [41] Seronegative Sjögren Syndrome: A Forgotten Entity?
    Lee, Adrian Y. S.
    Rischmueller, Maureen
    Reed, Joanne H.
    JOURNAL OF RHEUMATOLOGY, 2024, 51 (01) : 7 - 9
  • [42] Pulmonary Manifestations of Sjögren’s Syndrome
    George Stojan
    Alan N. Baer
    Sonye K. Danoff
    Current Allergy and Asthma Reports, 2013, 13 : 354 - 360
  • [43] Application of omics in Sjögren's syndrome
    He, Wenqin
    Lu, Yangyang
    Shi, Rongjing
    An, Qi
    Zhao, Jingwen
    Gao, Xinnan
    Zhang, Liyun
    Ma, Dan
    INFLAMMATION RESEARCH, 2023, 72 (12) : 2089 - 2109
  • [44] The genetics of primary Sjögren’s syndrome
    Amr H. Sawalha
    Robyn Potts
    Wendi R. Schmid
    R. Hal Scofield
    John B. Harley
    Current Rheumatology Reports, 2003, 5 (4) : 324 - 332
  • [45] Application of omics in Sjögren’s syndrome
    Wenqin He
    Yangyang Lu
    Rongjing Shi
    Qi An
    Jingwen Zhao
    Xinnan Gao
    Liyun Zhang
    Dan Ma
    Inflammation Research, 2023, 72 : 2089 - 2109
  • [46] Horizons in Sjögren’s Syndrome Genetics
    Pamela H. Williams
    Beth L. Cobb
    Bahram Namjou
    R. Hal Scofield
    Amr H. Sawalha
    John B. Harley
    Clinical Reviews in Allergy & Immunology, 2007, 32 : 201 - 209
  • [47] Sjögren’s Before Sjögren: Did Henrik Sjögren (1899–1986) Really Discover Sjögren’s Disease?
    M. Ghafoor
    Journal of Maxillofacial and Oral Surgery, 2012, 11 (3) : 373 - 374
  • [48] Rezidivierende Parotisabszesse beim Sjögren-SyndromRecurrent abcesses of the parotid gland in Sjögren’s syndrome
    A. Knopf
    A. Pickhard
    T. Stark
    S. Schulz
    E.Q. Scherer
    HNO, 2009, 57 : 959 - 964
  • [49] Ophthalmologische Komplikationen beim Sjögren-SyndromDiagnostik und TherapieOphthalmological complications in Sjögren’s syndrome
    C. Jacobi
    C. Cursiefen
    Zeitschrift für Rheumatologie, 2010, 69 (1) : 32 - 40
  • [50] Endoplasmic reticulum stress in the salivary glands of patients with primary Sjögren's syndrome, associated Sjögren's syndrome, and non-Sjögren's sicca syndrome: a comparative analysis and the influence of chloroquine
    Cavalcanti, Graziela Vieira
    de Oliveira, Fabiola Reis
    Bannitz, Rafael Ferraz
    de Paula, Natalia Aparecida
    Motta, Ana Carolina Fragoso
    Rocha, Eduardo Melani
    Chiorini, John
    Ricz, Hilton Marcos Alves
    Garcia, Denny Marcos
    Foss-Freitas, Maria Cristina
    de Freitas, Luiz Carlos Conti
    ADVANCES IN RHEUMATOLOGY, 2025, 65 (01):